- Home
- FORA vs ANVS Comparison
FORA vs ANVS Comparison
Compare FORA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FORA | ANVS |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.2M | 111.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FORA | ANVS |
|---|---|---|
| Price | $2.08 | $2.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 16.6K | ★ 314.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.92 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,153,263.00 | N/A |
| Revenue This Year | $51.82 | N/A |
| Revenue Next Year | $7.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.64 | $1.11 |
| 52 Week High | $2.71 | $5.50 |
Technical Indicators
Market Signals| Indicator | FORA | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 50.48 |
| Support Level | $2.05 | $2.27 |
| Resistance Level | $2.12 | $2.98 |
| Average True Range (ATR) | 0.02 | 0.19 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 60.00 | 50.77 |
Price Performance
Historical ComparisonAbout FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.